PubMed

Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2.

Tiberti C, Giordano C, Locatelli M, Bosi E, Bottazzo GF, Buzzetti R, Cucinotta D, Galluzzo A, Falorni A, Dotta F.

Diabetes. 2008 May;57(5):1276-83. Epub 2008 Mar 10.PMID: 18332100 [PubMed - indexed for MEDLINE]Related articlesFree article

Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies.

Gambelunghe G, Forini F, Laureti S, Murdolo G, Toraldo G, Santeusanio F, Brunetti P, Sanjeevi CB, Falorni A.

Clin Endocrinol (Oxf). 2000 May;52(5):565-73.PMID: 10792335 [PubMed - indexed for MEDLINE]Related articles

Autoantibody profile and epitope mapping in latent autoimmune diabetes in adults.

Falorni A, Calcinaro F.

Ann N Y Acad Sci. 2002 Apr;958:99-106.PMID: 12021088 [PubMed - indexed for MEDLINE]Related articles

Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.

Zanone MM, Catalfamo E, Pietropaolo SL, Rabbone I, Sacchetti C, Cerutti F, Trucco M, Cavallo-Perin P.

Metabolism. 2003 Jan;52(1):25-9.PMID: 12524658 [PubMed - indexed for MEDLINE]Related articles

Autoantibody negative new onset type 1 diabetic patients lacking high risk HLA alleles in a caucasian population: are these type 1b diabetes cases?

Tiberti C, Buzzetti R, Anastasi E, Dotta F, Vasta M, Petrone A, Cervoni M, Torresi P, Vecci E, Multari G, Di Mario U.

Diabetes Metab Res Rev. 2000 Jan-Feb;16(1):8-14.PMID: 10707033 [PubMed - indexed for MEDLINE]Related articles

Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.

Sabbah E, Savola K, Kulmala P, Reijonen H, Veijola R, Vähäsalo P, Karjalainen J, Ilonen J, Akerblom HK, Knip M.

Clin Exp Immunol. 1999 Apr;116(1):78-83.PMID: 10209508 [PubMed - indexed for MEDLINE]Related articlesFree article

Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.

Seissler J, de Sonnaville JJ, Morgenthaler NG, Steinbrenner H, Glawe D, Khoo-Morgenthaler UY, Lan MS, Notkins AL, Heine RJ, Scherbaum WA.

Diabetologia. 1998 Aug;41(8):891-7.PMID: 9726590 [PubMed - indexed for MEDLINE]Related articles

[Chronic complications in adult patients with newly diagnosed diabetes mellitus in relation to the presence of humoral autoimmune markers against pancreatic islet cells]

Szepietowska B, Szelachowska M, Górska M, Jakubczyk D, Kinalska I.

Pol Arch Med Wewn. 2004 May;111(5):563-9. Polish. PMID: 15508807 [PubMed - indexed for MEDLINE]Related articles

Diabetes-related antibodies in adult diabetic patients.

Falorni A, Brozzetti A.

Best Pract Res Clin Endocrinol Metab. 2005 Mar;19(1):119-33. Review.PMID: 15826926 [PubMed - indexed for MEDLINE]Related articles

[Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin]

Pánczél P, Hosszúfalusi N, Bornemisza B, Horváth L, Jánoskuti L, Füst G, Rajczy K, Vatay A, Prohászka Z, Madácsy L, Luczay A, Blatniczky L, Halmos T, Körner A, Szilvási I, Romics L.

Orv Hetil. 2001 Nov 18;142(46):2571-8. Hungarian. PMID: 11770176 [PubMed - indexed for MEDLINE]Related articles

Similar genetic features and different islet cell autoantibody pattern of latent autoimmune diabetes in adults (LADA) compared with adult-onset type 1 diabetes with rapid progression.

Hosszúfalusi N, Vatay A, Rajczy K, Prohászka Z, Pozsonyi E, Horváth L, Grosz A, Gerõ L, Madácsy L, Romics L, Karádi I, Füst G, Pánczél P.

Diabetes Care. 2003 Feb;26(2):452-7.PMID: 12547879 [PubMed - indexed for MEDLINE]Related articlesFree article

High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes.

Buzzetti R, Di Pietro S, Giaccari A, Petrone A, Locatelli M, Suraci C, Capizzi M, Arpi ML, Bazzigaluppi E, Dotta F, Bosi E; Non Insulin Requiring Autoimmune Diabetes Study Group.

Diabetes Care. 2007 Apr;30(4):932-8.PMID: 17392553 [PubMed - indexed for MEDLINE]Related articlesFree article

Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study.

Davis TM, Zimmet P, Davis WA, Bruce DG, Fida S, Mackay IR.

Diabet Med. 2000 Sep;17(9):667-74.PMID: 11051287 [PubMed - indexed for MEDLINE]Related articles

International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice.

Bonifacio E, Atkinson M, Eisenbarth G, Serreze D, Kay TW, Lee-Chan E, Singh B.

Diabetes. 2001 Nov;50(11):2451-8. Review.PMID: 11679421 [PubMed - indexed for MEDLINE]Related articlesFree article

Equivalent insulin resistance in latent autoimmune diabetes in adults (LADA) and type 2 diabetic patients.

Chiu HK, Tsai EC, Juneja R, Stoever J, Brooks-Worrell B, Goel A, Palmer JP.

Diabetes Res Clin Pract. 2007 Aug;77(2):237-44. Epub 2007 Jan 17.PMID: 17234296 [PubMed - indexed for MEDLINE]Related articles

Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes.

Pietropaolo M, Barinas-Mitchell E, Pietropaolo SL, Kuller LH, Trucco M.

Diabetes. 2000 Jan;49(1):32-8.PMID: 10615947 [PubMed - indexed for MEDLINE]Related articlesFree article

Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.

Sabbah E, Savola K, Kulmala P, Veijola R, Vähäsalo P, Karjalainen J, Akerblom HK, Knip M.

J Clin Endocrinol Metab. 1999 May;84(5):1534-9.PMID: 10323375 [PubMed - indexed for MEDLINE]Related articlesFree article

IA-2 combined epitope assay: a new, highly sensitive approach to evaluate IA-2 humoral autoimmunity in type 1 diabetes.

Tiberti C, Verrienti A, Fiore B, Yu L, Eisenbarth GS, Dotta F, Di Mario U.

Clin Immunol. 2005 Jun;115(3):260-7.PMID: 15893693 [PubMed - indexed for MEDLINE]Related articles

IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71).

Bottazzo GF, Bosi E, Cull CA, Bonifacio E, Locatelli M, Zimmet P, Mackay IR, Holman RR.

Diabetologia. 2005 Apr;48(4):703-8. Epub 2005 Mar 12. Erratum in: Diabetologia. 2005 Jun;48(6):1240. PMID: 15765222 [PubMed - indexed for MEDLINE]Related articles

[Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients]

Reinsch B, Zimmy S, Schatz H, Pfohl M.

Med Klin (Munich). 2003 Feb 15;98(2):67-71. German. PMID: 12601530 [PubMed - indexed for MEDLINE]Related articles